Final Program

WEDNESDAY • MAY 18 365
P117
P118
P119
P120
P121
Facilitator:
P122
P123
P124
P125
P126
P127
P128
P129
The Effect of Age, Gender, Body Mass Index (BMI), Emphysema
Lobe Predominance, and Exercise Capacity on Inspiratory
Muscle Strength After Lung Volume Reduction Surgery
(LVRS)/R.N. Criner, D. Yu, G.J. Criner, Philadelphia, PA, p.A6882
Endoscopic Lung Volume Reduction: Can Valves be safely
removed?/R.-H. Hubner, C. Grah, C. Thieme, C. Pizarro, B.
Temmesfeld-Wollbrueck, S. Hippenstiel, N. Suttorp, D. Skowasch,
Berlin, Germany, p.A6883
A Prospective Study of RejuvenAirT System Radial Spray
Cryotherapy to Determine Safety and Histological Effect in the
Lung/D. Breen, J. Coad, D.-J. Slebos, Galway, Ireland, p.A6884
Bronchoscopic Lung Volume Reduction: Proof of Original
Concept with New Image Technique/S.W. Lee, S.M. Lee, S.Y.
Shin, T.S. Park, J.S. Lee, Y.-M. Oh, S.-D. Lee, J.B. Seo, Seoul,
Korea, Republic of, p.A6885
The Role of Pulmonary Lobe Deflation Measurements in COPD
Patients Planned for Lung Volume Reduction/J. Hetzel, M.
Haentschel, W. Spengler, A. Ehab, S.D. Ioanoviciu, M. Horger,
Tuebingen, Germany, p.A6886
J. Porszasz, MD, PhD, Torrace, CA
Bronchoscopic Decompression for Severe Emphysema/A.
Kumar, L. Lam, T. Gildea, Y. Meli, X. Wang, A.C. Mehta, Cleveland,
OH, p.A6887
Review of Quality of Life Outcomes Following Use of an
Oscillating Positive Expiratory Pressure (OPEP) Device for
Chronic Obstructive Pulmonary Disease (COPD): 8 Weeks
Field Study Using the COPD Assessment Test (CAT)/J. Suggett,
5G4, Canada, p.A6888
A Placebo-Controlled, Randomized Trial of Mesenchymal Stem
Cells Associated with One-Way Endo-Bronchial Valves in Severe
COPD Patients/F.F. Cruz, H.G. De Oliveira, M.A.A. Almeida, A.V.D.M.
Neto, G.A. Oliveira, F.M. Svartman, C.L.K. Rebelatto, D.J. Weiss,
P.R.S. Brofman, P.R.M. Rocco, Rio de Janeiro, Brazil, p.A6889
Preoperative Predictors of Improvement with Lung Volume
Reduction Surgery/B.A. Whippo, P.A. Jellen, B.M. Thomashow, M.
Ginsburg, C. Chiuzan, Y. Zhang, W. Bulman, New York, NY, p.A6890
STEP-UP Randomized Controlled Trial of Segmental Vapor
Ablation in Patients with Severe Emphysema: 6 Month
Results/C.B. Strange, F.J.F. Herth, A. Valipour, P.L. Shah, R.
Eberhardt, C. Grah, J. Egan, J.H. Ficker, M. Wagner, C. Witt, U.
Liebers, P. Hopkins, W. Gesierich, M. Phillips, F. Stanzel, W. McNulty,
C. Petermann, G.I. Snell, D. Gompelmann, Charleston, SC, p.A7908
Positive Airway Pressure Therapies and Hospitalization Risk in
Chronic Obstructive Pulmonary Disease/M.M. Vasquez, L.A.
McClure, D.L. Sherrill, S. Guerra, S. Parthasarathy, Tucson, AZ, p.A7909
One Year Follow-Up After Endobronchial Valve Treatment in
Patients with Emphysema Without Interlobar Collateral
Ventilation/K. Klooster, J.E. Hartman, N.H.T. Ten Hacken, D.-J.
Slebos, Groningen, Netherlands, p.A7910
Effect of Yoga Breathing (Pranayama) on Exercise Tolerance
and Dynamic Hyperinflation in Patients with COPD/D.A.
Kaminsky, N.A. Hanania, K.K. Guntupalli, J. Lippman, S. Burns, M.
Brock, A. Mohsin, C. LaRock-McMahon, H. Pecott-Grimm, J. Skelly,
M. Desarno, P. Warren, M. Whitney, Burlington, VT, p.A7911
D40
THEMATIC POSTER SESSION
CRITICAL CARE: DIAGNOSING AND TREATING
BACTERIAL AND VIRAL INFECTIONS IN THE ICU
9:00 a.m. - 3:30 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area G, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitators: M.H. Kollef, MD, St. Louis, MO
K. Akrami, MD, Bethesda, MD
P691
P692
P693
P694
P695
P696
P697
Critically Ill Patients with the Middle East Respiratory
Syndrome (MERS): A Multicenter Study/Y.M. Arabi, A. ALOmari,
Y. Mandourah, F. Al-Hameed, A. Sindi, B. Al-Raddadi, S. Shalhoub,
A. Almotairi, I. Qushmaq, K. Alkhatib, A. Mady, O. Solaiman, A.
Abdulmomen, A. Alaithan, R. Alradadi, A. Rajab, G. Almekhlafi, A.
Alharthy, M. Alahmadi, M. Sadat, H. Almutairi, S. Abdukahil, E.
Alqasim, A. Toledo, M. Nasim, F. Bafqeeh, O. Alshankeety, A.
Anwar, A.S. Aldawood, L. Merson, R. Fowler, F. Hayden, H.
Balkhy, Riyadh, Saudi Arabia, p.A6891
Critically Ill Healthcare Workers with the Middle East
Respiratory Syndrome (MERS)/Y.M. Arabi, A. ALOmari, Y.
Mandourah, F. Al-Hameed, A. Sindi, B. Al-Raddadi, S. Shalhoub, A.
AlMotairi, K. Alkhatib, A. Abdulmomen, I. Qushmaq, A. Mady, O.
Solaiman, A. Alaithan, R. Alradadi, A. Rajab, G. Almekhlafi, A.
Alharthy, M. Alahmadi, M. Sadat, S. Abdukahil, A. Toledo, H.
Almutairi, E. Alqasim, A.S. Aldawood, L. Merson, R. Fowler, F.
Hayden, H. Balkhy, Riyadh, Saudi Arabia, p.A6982
Factors Associated with Recurrence and Mortality in Central
Line-Associated Bloodstream Infections/L.E. Huerta, G. Nelson,
T.W. Rice, Nashville, TN, p.A6893
Anatomic Site-Specific Complication Rates for Central Venous
Catheter Insertions/J.H. Garfinkel, S. Long, M. Goyal, J. Bell, J.M.
Friedrich, A. Kumar, K. Blythe, J. Keyloun, S. Chung, R.
Molyneaux, K. Yusuf, S. Fitzgibbons, Washington, DC, p.A6894
Comparison Between Chlorhexidine Gluconate Impregnated
Dressings and Skin Antisepsis in the Prevention of Catheter
Related Blood Stream Infections in the Intensive Care Unit: A
Prospective Randomized Controlled Trial/K. Rivera Manzano, C.
Betancourt, R. Fernandez Gonzalez, R.A. Hernandez, R.
Fernandez, R. Reyes, San Juan, PR, p.A6895
CLABSI Data and Numeracy Among Clinicians: Results of a
Twitter-Based International Survey/S. Govindan, V. Chopra, T.J.
Iwashyna, Ann Arbor, MI, p.A6896
Ascorbic Acid Attenuates Hyperoxia-Compromised Host
Defense Against Pulmonary Bacterial Infection/V. Patel, V.
Sampat, M.G. Espey, R. Sitapara, H. Wang, X. Yang, C.R. Ashby,
D.D. Thomas, L.L. Mantell, Jamaica, NY, p.A6897
WEDNESDAY MORNING
ATS 2016 • San Francisco